Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs
- 1 October 1999
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 146 (2) , 259-270
- https://doi.org/10.1016/s0021-9150(99)00146-x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Regulated Co-translational Ubiquitination of Apolipoprotein B100Journal of Biological Chemistry, 1998
- Cerivastatin in the treatment of mixed hyperlipidemia: the right studyThe American Journal of Cardiology, 1998
- Inhibition of HMG-CoA Reductase by Atorvastatin Decreases Both VLDL and LDL Apolipoprotein B Production in Miniature PigsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Suppression of Lipid Transfer Inhibitor Protein Activity by OleateArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Regulation of hepatic apolipoprotein-B-containing lipoprotein secretionCurrent Opinion in Lipidology, 1996
- Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemiaClinical Cardiology, 1995
- Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: Atorvastatin versus lovastatinAtherosclerosis, 1995
- Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.Journal of Clinical Investigation, 1991
- Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1975